|
GB587992A
(en)
|
1944-12-11 |
1947-05-12 |
Charles William Scaife |
Improvements in and relating to the production of organic nitrogen compounds
|
|
US3578687A
(en)
|
1968-01-30 |
1971-05-11 |
Texaco Inc |
Process for producing 4-nitroalkanoic acids
|
|
US3819561A
(en)
|
1970-10-23 |
1974-06-25 |
Aerojet General Co |
Wetting agents for non-aqueous dispersions
|
|
JPS5313608B2
(da)
|
1972-06-16 |
1978-05-11 |
|
|
|
JPS5318013B2
(da)
|
1973-03-19 |
1978-06-13 |
|
|
|
US4599430A
(en)
|
1981-12-21 |
1986-07-08 |
The Standard Oil Company |
Nitrogenation of hydrocarbons, including the production of maleimide
|
|
JPS62132804A
(ja)
|
1985-12-05 |
1987-06-16 |
Aguro Kanesho Kk |
植物生長調節剤
|
|
US5412137A
(en)
|
1993-06-07 |
1995-05-02 |
Sandoz Ltd. |
Process for preparing phosphinyloxy propanaminium inner salt derivatives
|
|
CN1138541C
(zh)
|
1994-08-08 |
2004-02-18 |
德彪药品股份有限公司 |
一种药学上稳定的奥沙利铂制剂
|
|
CA2202503C
(en)
|
1994-10-13 |
2008-07-15 |
Antonio Ferrante |
Modified polyunsaturated fatty acids
|
|
US5919816A
(en)
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
|
US5741211A
(en)
|
1995-10-26 |
1998-04-21 |
Medtronic, Inc. |
System and method for continuous monitoring of diabetes-related blood constituents
|
|
GB9618420D0
(en)
|
1996-09-04 |
1996-10-16 |
Scotia Holdings Plc |
Fatty acid treatment
|
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
WO1999022719A1
(fr)
|
1997-10-30 |
1999-05-14 |
Morishita Jintan Co., Ltd. |
Preparation de capsule contenant un acide gras insature ou un derive de celui-ci, et procede de fabrication
|
|
CH693954A5
(de)
|
1997-11-12 |
2004-05-14 |
Bayer Ag |
2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase Inhibitoren.
|
|
US7795246B2
(en)
|
1998-08-06 |
2010-09-14 |
Cephalon, Inc. |
Particle-forming compositions containing fused pyrrolocarbazoles
|
|
WO2000009075A2
(en)
|
1998-08-14 |
2000-02-24 |
Galenica Pharmaceuticals, Inc. |
Chemically modified saponins and the use thereof as adjuvants
|
|
ID29790A
(id)
|
1999-01-20 |
2001-10-11 |
Dresden Arzneimittel |
PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
|
|
MXPA01009893A
(es)
|
1999-04-01 |
2003-07-28 |
Esperion Therapeutics Inc |
Compuestos con eter, composiciones y usos de estos.
|
|
WO2001006983A2
(en)
|
1999-07-22 |
2001-02-01 |
Incell Corporation, Llc |
Fatty acids to minimize cancer therapy side effects
|
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
|
AUPQ291499A0
(en)
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
US6346231B1
(en)
|
1999-10-06 |
2002-02-12 |
Joar Opheim |
Flavored gelatin capsule and method of manufacture
|
|
IL139457A0
(en)
|
1999-11-08 |
2001-11-25 |
Pfizer |
Compounds for the treatment of female sexual dysfunction
|
|
US20010037598A1
(en)
|
1999-12-14 |
2001-11-08 |
Suppes Galen J. |
Process for producing cetane improvers from triglycerides
|
|
DE60144401D1
(de)
|
2000-02-16 |
2011-05-19 |
Brigham & Womens Hospital |
Aspirin-ausgelöste Lipidmediatoren
|
|
AR034120A1
(es)
|
2000-04-13 |
2004-02-04 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
|
|
AR032318A1
(es)
|
2000-04-13 |
2003-11-05 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
|
|
AR030416A1
(es)
|
2000-04-13 |
2003-08-20 |
Pharmacia Corp |
COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA
|
|
CN1232480C
(zh)
|
2000-06-28 |
2005-12-21 |
萨宝集团公司 |
制备硝基烯烃的方法
|
|
AR031129A1
(es)
|
2000-09-15 |
2003-09-10 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
|
|
ES2287238T3
(es)
|
2001-03-02 |
2007-12-16 |
Debiopharm S.A. |
Utilizacion de un vial que contiene una solucion de oxaliplatino.
|
|
EE200300510A
(et)
|
2001-04-18 |
2004-02-16 |
Prometic Biosciences Inc. |
Keskmise pikkusega ahelaga rasvhapped, glütseriidid ja nende analoogid kui neutrofiilide ellujäämis- ja aktiveerimisfaktorid
|
|
US7105556B2
(en)
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
|
EP1407767A4
(en)
|
2001-06-18 |
2007-01-24 |
Yamada Sachiko |
AGONIST MEDICINAL PREPARATIONS PPAR $ G (G)
|
|
JP2005501096A
(ja)
|
2001-08-17 |
2005-01-13 |
ユニヴァーシティ オブ ピッツバーグ |
肥満、代謝症候群、糖尿病、血管障害及び腎臓疾患を治療又は予防するエストラジオールメタボライトの投与
|
|
GB0123961D0
(en)
|
2001-10-05 |
2001-11-28 |
Astrazeneca Ab |
Process and intermediates
|
|
KR20040053210A
(ko)
|
2001-11-02 |
2004-06-23 |
화이자 프로덕츠 인크. |
Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
|
|
HN2002000317A
(es)
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
WO2003039533A1
(en)
|
2001-11-06 |
2003-05-15 |
The Brigham And Women's Hospital, Inc. |
Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
|
|
GB2388111A
(en)
|
2002-05-01 |
2003-11-05 |
Bayer Ag |
Novel imidazotriazinone compounds
|
|
US6684626B1
(en)
|
2002-07-30 |
2004-02-03 |
General Electric Company |
Aircraft gas turbine engine with control vanes for counter rotating low pressure turbines
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
MXPA05002883A
(es)
|
2002-08-20 |
2005-10-05 |
Protemix Corp Ltd |
Formas de dosis y terapias relacionadas.
|
|
WO2004028469A2
(en)
|
2002-09-27 |
2004-04-08 |
Martek Biosciences Corporation |
Docohexaenoic acid for improved glycemic control
|
|
US7326421B2
(en)
|
2002-10-21 |
2008-02-05 |
Kensey Nash Corporation |
Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
WO2005016864A1
(en)
|
2003-07-29 |
2005-02-24 |
The Arizona Disease Control Research Commission |
Conjugated nitro alkene anticancer agents based on isoprenoid metabolism
|
|
US20050136103A1
(en)
|
2003-09-17 |
2005-06-23 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
|
US7935365B2
(en)
|
2003-10-22 |
2011-05-03 |
Enzymotec, Ltd. |
Glycerophospholipids for the improvement of cognitive functions
|
|
CA2543522A1
(en)
|
2003-10-31 |
2005-05-12 |
Pfizer Products Inc. |
Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
|
|
BRPI0507236A
(pt)
|
2004-01-30 |
2007-06-26 |
Peplin Biolipids Pty Ltd |
método para o tratamento ou profilaxia de uma condição, e, composto
|
|
MXPA06011871A
(es)
|
2004-04-15 |
2007-10-08 |
Chiasma Inc |
Composiciones capaces de facilitar la penetracion a traves de una barrera biologica.
|
|
WO2005110396A2
(en)
|
2004-04-28 |
2005-11-24 |
Uab Research Foundation |
Nitrated lipids and methods of making and using thereof
|
|
CN101027318B
(zh)
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物，制剂及其用途
|
|
MY139689A
(en)
|
2004-07-20 |
2009-10-30 |
Osi Pharm Inc |
Imidazotriazines as protein kinase inhibitors
|
|
WO2006011397A1
(ja)
|
2004-07-27 |
2006-02-02 |
Kowa Company., Ltd. |
糖尿病の予防または治療のための薬剤
|
|
EA010802B1
(ru)
|
2004-11-19 |
2008-12-30 |
Мартек Байосайенсиз Корпорейшн |
Оксилипины из полиненасыщенных жирных кислот с длинной цепью и способы их получения и применения
|
|
WO2006058250A2
(en)
|
2004-11-24 |
2006-06-01 |
Spi Pharma, Inc. |
Orally disintegrating compositions
|
|
AU2011202664B2
(en)
|
2004-12-08 |
2012-04-05 |
Cedars-Sinai Medical Center |
Methods for diagnosis and treatment of Crohn's disease
|
|
US20070032420A1
(en)
|
2005-02-09 |
2007-02-08 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
|
WO2007028051A2
(en)
|
2005-09-02 |
2007-03-08 |
Abbott Laboratories |
Novel imidazo based heterocycles
|
|
GB0522569D0
(en)
|
2005-11-04 |
2005-12-14 |
Univ Bath |
Biocompatible drug delivery device
|
|
TW200815436A
(en)
|
2006-05-30 |
2008-04-01 |
Elbion Ag |
4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
US9274129B2
(en)
|
2006-05-31 |
2016-03-01 |
Lpath, Inc. |
Methods and reagents for detecting bioactive lipids
|
|
WO2008008767A2
(en)
|
2006-07-14 |
2008-01-17 |
Cedars-Sinai Medical Center |
Methods of using ppar-gamma agonists and caspase-dependent chemotherapeutic agents for the treatment of cancer
|
|
RU2009101324A
(ru)
|
2006-07-19 |
2010-07-27 |
Ризолвикс Фармасьютикалз, Инк. (Us) |
Композиции и способы лечения воспаления слизистой оболочки
|
|
CA2662594A1
(en)
|
2006-09-08 |
2008-03-13 |
Tokuyama Corporation |
Method and apparatus for producing a group iii nitride
|
|
CN101557826A
(zh)
|
2006-12-13 |
2009-10-14 |
Aska制药株式会社 |
泌尿系统疾病的治疗药
|
|
US8299080B2
(en)
|
2006-12-13 |
2012-10-30 |
Aska Pharmaceutical Co., Ltd. |
Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
|
|
CN101663031A
(zh)
|
2007-02-20 |
2010-03-03 |
马泰克生物科学公司 |
来自长链多不饱和脂肪酸的氧脂素及其制备方法和使用方法
|
|
SI2152712T1
(sl)
|
2007-05-11 |
2012-03-30 |
Pfizer |
Amino heterociklične spojine
|
|
DE102007032349A1
(de)
|
2007-07-11 |
2009-01-15 |
Bayer Healthcare Ag |
Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
|
|
WO2009017802A1
(en)
|
2007-08-01 |
2009-02-05 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Nitro-fattyacid modulation of type ii diabetes
|
|
US20090137527A1
(en)
|
2007-09-14 |
2009-05-28 |
Resolvyx Pharmaceuticals, Inc. |
Compositions and methods for modulating immune function
|
|
US20110092594A1
(en)
|
2008-04-18 |
2011-04-21 |
Tianxin Yang |
Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions
|
|
WO2009134383A2
(en)
|
2008-05-01 |
2009-11-05 |
Complexa Inc. |
Vinyl substituted fatty acids
|
|
WO2009149496A1
(en)
|
2008-06-10 |
2009-12-17 |
Central Northern Adelaide Health Service |
Treatment of diabetes and complications thereof and related disorders
|
|
US20140024713A1
(en)
|
2008-06-19 |
2014-01-23 |
University Of Utah Research Foundation |
Use of nitrated lipids for treatment of side effects of toxic medical therapies
|
|
US8686038B2
(en)
|
2008-06-19 |
2014-04-01 |
The Univsersity of Utah Research Foundation |
Use of nitrated lipids for treatment of side effects of toxic medical therapies
|
|
EP2320903B1
(en)
|
2008-07-29 |
2017-01-18 |
Nerviano Medical Sciences S.r.l. |
THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT
|
|
CA2984026C
(en)
|
2008-10-09 |
2020-02-11 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
US8937194B2
(en)
|
2008-12-31 |
2015-01-20 |
Nitromega Corp. |
Topical compositions containing nitro fatty acids
|
|
CN102307464A
(zh)
|
2008-12-31 |
2012-01-04 |
尼特罗米加公司 |
含有硝基脂肪酸的营养制品
|
|
TWI404721B
(zh)
|
2009-01-26 |
2013-08-11 |
Pfizer |
胺基－雜環化合物
|
|
US20100286257A1
(en)
|
2009-05-08 |
2010-11-11 |
Perricone Nicholas V |
Methods Of Use Of Nitroalkane Compositions In Dermatologic Applications To Prevent or Treat Skin Aging
|
|
US20100286271A1
(en)
|
2009-05-08 |
2010-11-11 |
Perricone Nicholas V |
Nitro-alkyl Compound Compositions
|
|
US20100286272A1
(en)
|
2009-05-08 |
2010-11-11 |
Perricone Nicholas V |
Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
|
|
US20110082147A1
(en)
|
2009-07-24 |
2011-04-07 |
Concert Pharmaceuticals, Inc. |
Substituted imidazotriazines
|
|
KR20120046754A
(ko)
|
2009-07-29 |
2012-05-10 |
페노미넘 디스커버리스 인코포레이티드 |
히드록시 지방산 화합물 및 질병 치료 및 진단을 위한 그의 용도
|
|
WO2011014261A1
(en)
|
2009-07-31 |
2011-02-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Fatty acids as anti-inflammatory agents
|
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
WO2011030351A2
(en)
|
2009-09-03 |
2011-03-17 |
Rubicon Research Private Limited |
Taste - masked pharmaceutical compositions
|
|
US8686167B2
(en)
|
2009-10-02 |
2014-04-01 |
Complexa, Inc. |
Heteroatom containing substituted fatty acids
|
|
JP2013510145A
(ja)
|
2009-11-09 |
2013-03-21 |
メディヴィル・アクチエボラーグ |
１，３−オキサゾリジン化合物およびレニン阻害剤としてのそれらの使用方法
|
|
WO2011098746A1
(en)
|
2010-02-09 |
2011-08-18 |
Pulmagen Therapeutics (Inflammation) Limited |
Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
|
|
CN102970972B
(zh)
|
2010-03-15 |
2015-12-16 |
安雷戚·迪兹 |
硝基羧酸用于治疗、诊断和预防侵袭性愈合模式的用途
|
|
JP2013526865A
(ja)
|
2010-05-13 |
2013-06-27 |
ニトロメガ コーポレーション |
ニトロ脂肪酸、神経保護および／または認識減退の抑制
|
|
JP2013534930A
(ja)
|
2010-06-28 |
2013-09-09 |
コンプレクサ，インコーポレイテッド |
糖尿病を治療するための多成分調剤
|
|
MX2013003093A
(es)
|
2010-09-20 |
2013-10-28 |
Envivo Pharmaceuticals Inc |
Compuestos de imidazotriazinona.
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
WO2013028501A1
(en)
|
2011-08-19 |
2013-02-28 |
The University Of Utah Research Foundation |
Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
|
|
RU2605096C2
(ru)
|
2011-10-07 |
2016-12-20 |
ЭЙСАЙ АрЭНДДи МЕНЕДЖМЕНТ КО., ЛТД. |
Пиразолохинолиновое производное
|
|
EP2906562B1
(en)
|
2011-10-10 |
2016-10-05 |
H. Lundbeck A/S |
Pde9i with imidazo pyrazinone backbone
|
|
US9271952B2
(en)
|
2011-10-11 |
2016-03-01 |
Complexa, Inc. |
Compositions and methods for treating nephropathy
|
|
DE102012008730A1
(de)
|
2011-12-02 |
2013-06-06 |
Dr. Budz GmbH |
Orale Zusammensetzungen mit ungesättigten C18-Fettsäuren und ihre Verwendung
|
|
AU2013213603B2
(en)
|
2012-01-26 |
2017-02-02 |
H. Lundbeck A/S |
PDE9 inhibitors with imidazo triazinone backbone
|
|
CN104136423B
(zh)
|
2012-02-01 |
2019-03-08 |
希望之城 |
核糖核苷酸还原酶抑制剂和使用方法
|
|
JP2015508065A
(ja)
|
2012-02-03 |
2015-03-16 |
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
抗炎症薬としての脂肪酸
|
|
US10435367B2
(en)
|
2013-03-14 |
2019-10-08 |
City Of Hope |
Indirubin derivatives, and uses thereof
|
|
WO2013142269A1
(en)
|
2012-03-19 |
2013-09-26 |
Envivo Pharmaceuticals, Inc. |
Imidazotriazinone compounds
|
|
US10058688B2
(en)
|
2012-05-09 |
2018-08-28 |
Massachusetts Institute Of Technology |
Medicament, method, and drug delivery device for treatment of ovarian cancer
|
|
BR112015003836A2
(pt)
|
2012-08-31 |
2017-07-04 |
Taris Biomedical Llc |
sistemas e métodos para distribuição de drogas para tratamento de câncer de bexiga
|
|
US20140271844A1
(en)
|
2013-03-15 |
2014-09-18 |
Nitromega Corp. |
Compositions containing nitro fatty acids
|
|
ES2762555T3
(es)
|
2013-04-10 |
2020-05-25 |
Massachusetts Inst Technology |
Dispositivos y métodos de administración local de fármacos para el tratamiento del cáncer
|
|
CN105339006A
(zh)
|
2013-05-10 |
2016-02-17 |
尼特罗米加公司 |
含有脂肪酸和亚硝酸盐的营养或膳食补充剂
|
|
WO2014204872A2
(en)
|
2013-06-14 |
2014-12-24 |
Complexa, Inc. |
Composition and method for inhibition of pkng from mycobacterium tuberculosis
|
|
CN105744983B
(zh)
|
2013-08-12 |
2019-12-27 |
纳米医学系统公司 |
用于缓释在增溶剂中的低水溶性治疗剂的装置和方法
|
|
WO2015073527A1
(en)
|
2013-11-12 |
2015-05-21 |
Complexa, Inc. |
Nitroalkene tocopherols and analogs thereof for use in the treatment and prevention of inflammation related conditions
|
|
WO2015185499A1
(en)
|
2014-06-06 |
2015-12-10 |
H. Lundbeck A/S |
Pde9 inhibitors with 1-benzyl-2,5,6,8-tetrahydro-3-oxo-2,7-naphthyridine-4-carbonitrile backbone
|
|
CA2961489A1
(en)
|
2014-09-17 |
2016-03-24 |
Glen Robert RENNIE |
Sgc stimulators
|
|
WO2016161285A1
(en)
|
2015-04-02 |
2016-10-06 |
Aobiome Llc |
Production of nitro-fatty acids and nitro-hydrocarbons by ammonia oxidizing bacteria
|
|
EP3303339B1
(en)
|
2015-07-07 |
2021-01-13 |
H. Lundbeck A/S |
Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
|
|
CN113440506A
(zh)
|
2015-10-02 |
2021-09-28 |
康普莱克夏公司 |
使用治疗有效量的活化脂肪酸预防、治疗和逆转疾病
|
|
KR102746242B1
(ko)
|
2016-02-19 |
2024-12-23 |
피닉스 몰레큘라 디자인스 |
Ｒｓｋ 억제제로서 유용한 카르복사미드 유도체
|
|
WO2018009424A1
(en)
|
2016-07-06 |
2018-01-11 |
Imara, Inc. |
Pde9 inhibitors for treatment of peripheral diseases
|
|
WO2018218104A1
(en)
|
2017-05-26 |
2018-11-29 |
Imara, Inc. |
Methods of making and using pde9 inhibitors
|
|
KR20210014662A
(ko)
|
2018-05-25 |
2021-02-09 |
이마라 인크. |
6-[(3S,4S)-4-메틸-1-(피리미딘-2-일메틸)피롤리딘-3-일]-3-테트라히드로피란-4-일-7H-이미다조[1,5-a]피라진-8-온의 일수화물 및 결정형
|
|
EP3843737A4
(en)
|
2018-08-31 |
2022-06-01 |
Imara Inc. |
PDE9 INHIBITORS FOR THE TREATMENT OF SICKLE CELL DISEASE
|
|
EP3946348A4
(en)
|
2019-04-05 |
2023-08-02 |
Imara Inc. |
PDE9 INHIBITORS FOR THE TREATMENT OF SICKLE CELL DISEASE
|
|
CN114072151A
(zh)
|
2019-05-07 |
2022-02-18 |
伊马拉公司 |
用于治疗地中海贫血的pde9抑制剂
|
|
WO2022036111A1
(en)
|
2020-08-13 |
2022-02-17 |
Imara Inc. |
Methods and compositions for treating sickle cell disease
|
|
KR20230128450A
(ko)
|
2020-10-27 |
2023-09-05 |
카듀리온 파마슈티칼스, 인크. |
심부전 치료를 위한 pde9 억제제
|